Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Taking medication for hair loss might cause sexual problems.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Androgenic alopecia is male or female pattern baldness.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Finasteride causes reproductive changes in male rats.

Finasteride may improve prostate cancer treatment outcomes.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Growth hormone therapy boosts androgen effects on skin in men.

Male pattern baldness may be linked to prostate cancer risk.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.